The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Recently, research teams led by Professor Cai Songhua from the Shenzhen Branch of the Cancer Hospital of the Chinese Academy of Medical Sciences, Professor Mao Wenjun from Wuxi People's Hospital, and ...

Cancer remains one of the most strong challenges existing in modern medicine as of today, making it necessary to innovate strategies to combat its relentless progression. Out of the many strategies ...

The tumor-suppressing role of miR-455-3p has been reported in lung cancer, but the working mechanism remains to be fully elucidated. This study aims to explore the possible mechanism of miR-455-3p in ...

Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a small clinical trial led ...

Breast cancer's resistance to treatment is a major hurdle in improving patient outcomes. A recent study explores how tumor angiogenesis—the formation of abnormal blood vessels in tumors—plays a ...